208 related articles for article (PubMed ID: 6445103)
21. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow.
Hale DA; Gottschalk R; Maki T; Monaco AP
Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619
[TBL] [Abstract][Full Text] [Related]
22. The effect of timing of skin grafts on subsequent survival in ALS-treated, marrow-infused mice.
Wood ML; Monaco AP
Transplantation; 1977 Jan; 23(1):78-86. PubMed ID: 65036
[TBL] [Abstract][Full Text] [Related]
23. Effect of asialofetuin on prolongation of skin allograft survival by donor bone marrow cells.
Khouri W; Masli S; De Fazio SR; Gozzo JJ
Transplantation; 1994 Feb; 57(3):440-6. PubMed ID: 7509090
[TBL] [Abstract][Full Text] [Related]
24. Induction of allograft tolerance with neonatal skin.
Jamshidi F; De Fazio SR; Markees TG; Gozzo JJ
Transplantation; 1991 May; 51(5):1048-52. PubMed ID: 2031261
[TBL] [Abstract][Full Text] [Related]
25. Adoptive transfer of specific unresponsiveness to skin allografts by spleen cells from ALS-treated, marrow-injected mice.
Wood ML; Monaco AP
Transplant Proc; 1979 Mar; 11(1):1023-7. PubMed ID: 377604
[No Abstract] [Full Text] [Related]
26. Requirement for early donor cell chimerism during prolonged survival of murine skin allografts.
Masli S; De Fazio SR; Gozzo JJ
Transplantation; 2000 Apr; 69(8):1667-75. PubMed ID: 10836379
[TBL] [Abstract][Full Text] [Related]
27. Models of specific unresponsiveness to tissue allografts in antilymphocyte serum (ALS) treated mice.
Wood ML; Monaco AP
Transplant Proc; 1978 Jun; 10(2):379-87. PubMed ID: 354127
[No Abstract] [Full Text] [Related]
28. Prolongation of impure murine islet allografts with antilymphocyte serum and donor-specific bone marrow.
Markees TG; De Fazio SR; Gozzo JJ
Transplantation; 1992 Mar; 53(3):521-7. PubMed ID: 1549842
[TBL] [Abstract][Full Text] [Related]
29. Induction of suppressor cell mechanism in antilymphocyte serum-induced skin allograft tolerance in mice.
Rieger M; Hilgert I; Kristofová H; Vlachov K
Folia Biol (Praha); 1979; 25(4):220-30. PubMed ID: 159195
[TBL] [Abstract][Full Text] [Related]
30. Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice: long-term survival of allogeneic bone marrow and skin grafts.
Slavin S; Strober S; Fuks Z; Kaplan HS
J Exp Med; 1977 Jul; 146(1):34-48. PubMed ID: 17647
[TBL] [Abstract][Full Text] [Related]
31. Cloning of self-major histocompatibility complex antigen-specific suppressor cells from adult bone marrow.
Takahashi T; Mafune K; Maki T
J Exp Med; 1990 Sep; 172(3):901-9. PubMed ID: 2143775
[TBL] [Abstract][Full Text] [Related]
32. Functional characteristics of a Ficoll-separated mouse bone marrow cell population involved in skin allograft prolongation.
Gozzo JJ; Crowley M; Maki T; Monaco AP
J Immunol; 1982 Oct; 129(4):1584-8. PubMed ID: 6213717
[TBL] [Abstract][Full Text] [Related]
33. The effect of timing of multiple donor-specific or nonspecific blood transfusions on skin allograft survival in ALS-treated mice.
Wood ML; Gottschalk R; Monaco AP
Transplantation; 1983 Oct; 36(4):388-91. PubMed ID: 6353706
[TBL] [Abstract][Full Text] [Related]
34. Induction of transplantation tolerance in rats by spleen allografts. II. Evidence that W3/25+ T suppressor/inducer and OX8+ T suppressor/effector cells are required to mediate specific unresponsiveness.
Stepkowski SM; Bitter-Suermann H; Duncan WR
Transplantation; 1987 Sep; 44(3):443-8. PubMed ID: 2957840
[TBL] [Abstract][Full Text] [Related]
35. In vitro modification of donor bone marrow used to produce enhanced graft survival in antilymphocyte serum (ALS)-treated mice.
Gozzo JJ; Wood ML; Pompei R; Monaco AP
Transplant Proc; 1973 Mar; 5(1):853-6. PubMed ID: 4572148
[No Abstract] [Full Text] [Related]
36. Effects of Corynebacterium granulosum on weight and histology of lymphoid organs, response to mitogens, skin allografts, and a syngeneic fibrosarcoma in mice.
Milas L; Basic I; Kogelnik HD; Withers HR
Cancer Res; 1975 Sep; 35(9):2365-74. PubMed ID: 807323
[TBL] [Abstract][Full Text] [Related]
37. Regulatory T cells maintain peripheral tolerance to islet allografts induced by intrathymic injection of MHC class I allopeptides.
Saborio DV; Chowdhury NC; Jin MX; Chandraker A; Sayegh MH; Oluwole SF
Cell Transplant; 1999; 8(4):375-81. PubMed ID: 10478717
[TBL] [Abstract][Full Text] [Related]
38. An essential role for natural killer cells in augmentation of allograft survival mediated by donor spleen cells.
Goldstein DR; Thomas JM; Kirklin JK; George JF
Transplantation; 2001 Sep; 72(5):954-6. PubMed ID: 11571465
[TBL] [Abstract][Full Text] [Related]
39. Tolerogenic behavior of skin allografts from neonatal mice.
Markees TG; De Fazio SR; Gozzo JJ
Transplantation; 1994 Nov; 58(9):1008-14. PubMed ID: 7974727
[TBL] [Abstract][Full Text] [Related]
40. Mouse skin graft prolongation with donor strain bone marrow and anti-lymphocyte serum: surface markers of the active bone marrow cells.
De Fazio S; Hartner WC; Monaco AP; Gozzo JJ
J Immunol; 1985 Nov; 135(5):3034-8. PubMed ID: 2864375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
